This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Small Animal Imaging (In Vivo) Market - By Systems And Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts To 2017

In 2012, North America accounted for the biggest market share with about 38.2% share of the global small animal imaging (in vivo) systems and reagents market, followed by Europe. Though the Asian and Latin American countries signify to be the fastest growing markets due to growing number of research institutions and CRO's, increasing government support for research and rising industry-academia partnerships for small animal research. The negative factors such as high competition in mature countries, economic slowdown and pricing pressures and will oblige the companies to focus on the Asian market.

Small animal imaging market seems to be highly competitive, as each player is focusing to gain a large market share. Rapid industry consolidation is a burning issue which is affecting the small market players and also forcing the major players to alter their marketing strategies.

This report includes company profiles of major players such as Bruker Corporation (U.S.), Siemens AG ( Germany), Life Technologies Corporation (U.S.), FUJIFILM Holdings Corporation ( Japan), Miltenyi Biotec GmbH ( Germany), PerkinElmer, Inc. (U.S.), Bioscan, Inc. (U.S.), Mediso Medical Imaging Systems ( Hungary), Gamma Medica (U.S.), Aspect Imaging ( Israel), Targeson, Inc. (U.S.) and Scanco Medical ( Switzerland).

 

TABLE OF CONTENTS

 

1 INTRODUCTION 19

1.1 KEY TAKE-AWAYS 19

1.2 REPORT DESCRIPTION 19

1.3 MARKETS COVERED 20

1.4 STAKEHOLDERS 22

1.5 RESEARCH METHODOLOGY 22

1.5.1 MARKET SIZE 22

1.5.2 MARKET SHARE 23

1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES 23

1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES 23

1.5.5 ASSUMPTIONS 24

 

2 EXECUTIVE SUMMARY 25

 

3 MARKET OVERVIEW 31

3.1 INTRODUCTION 32

3.2 MARKET SEGMENTATION 35

3.2.1 SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY 35

2 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,683.78 -46.33 -0.26%
S&P 500 2,072.85 -3.93 -0.19%
NASDAQ 4,998.5170 -10.6970 -0.21%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs